ArticleFrontiers in pharmacology2025

Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study.

Manuela Casula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.